• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药:慢性抑郁症中的部分缓解情况。

Antidepressants: partial response in chronic depression.

作者信息

Fawcett J

机构信息

Rush-Presbyterian-St Luke's Medical Center, Chicago, Illinois.

出版信息

Br J Psychiatry Suppl. 1994 Dec(26):37-41.

PMID:7873136
Abstract

Although most studies of chronic depression show significant improvements with antidepressants versus placebo, the average Hamilton Depression Rating Scale results attained in the active-treatment group range between 10 and 14, suggesting that many patients only partially responded and failed to reach premorbid levels of symptom remission. Studies on the fate of these patients suggest that they are much more vulnerable to relapse, work impairment and suicide. Thus, partial response may be one form of treatment resistance, falling between total failure of response in a minority of patients, and a tendency to relapse or recur despite adequate maintenance treatment. Further study is needed to address the problem of improving the quality of response and attempting to reduce the detrimental effects of depressive illness in terms of relapse and recurrence.

摘要

尽管大多数关于慢性抑郁症的研究表明,与安慰剂相比,抗抑郁药能带来显著改善,但积极治疗组的汉密尔顿抑郁量表平均得分在10至14之间,这表明许多患者只是部分有反应,未能达到病前症状缓解水平。对这些患者预后的研究表明,他们更容易复发、出现工作障碍和自杀。因此,部分反应可能是治疗抵抗的一种形式,介于少数患者完全无反应和尽管维持治疗充分仍有复发倾向之间。需要进一步研究来解决提高反应质量的问题,并试图减少抑郁症在复发和再发方面的有害影响。

相似文献

1
Antidepressants: partial response in chronic depression.抗抑郁药:慢性抑郁症中的部分缓解情况。
Br J Psychiatry Suppl. 1994 Dec(26):37-41.
2
Antidepressants and suicide prevention in Hungary.匈牙利的抗抑郁药与自杀预防
Acta Psychiatr Scand. 2001 Mar;103(3):238-9. doi: 10.1034/j.1600-0447.2001.103003238.x.
3
Pharmacotherapy in the prevention of suicidal behavior.预防自杀行为的药物治疗。
J Clin Psychopharmacol. 1992 Apr;12(2 Suppl):27S-31S.
4
Treatment of major depression: is improvement enough?重度抑郁症的治疗:改善就足够了吗?
J Clin Psychiatry. 1999;60 Suppl 6:10-4.
5
Antidepressive therapy in depressed clinical suicides.
Acta Psychiatr Scand. 1985 Feb;71(2):111-6. doi: 10.1111/j.1600-0447.1985.tb01261.x.
6
Suicide and major depression.自杀与重度抑郁症。
Am J Psychiatry. 2003 Jun;160(6):1192-3; author reply 1193. doi: 10.1176/appi.ajp.160.6.1192.
7
Suicide and antidepressants.自杀与抗抑郁药。
Drugs. 1992;43 Suppl 2:24-30; discussion 30-1. doi: 10.2165/00003495-199200432-00005.
8
Antidepressants and suicide: population benefit vs. individual risk.抗抑郁药与自杀:群体获益与个体风险
Acta Psychiatr Scand. 2010 Dec;122(6):442-3. doi: 10.1111/j.1600-0447.2010.01622.x.
9
Expanding the black box - depression, antidepressants, and the risk of suicide.打开黑匣子——抑郁症、抗抑郁药与自杀风险
N Engl J Med. 2007 Jun 7;356(23):2343-6. doi: 10.1056/NEJMp078015. Epub 2007 May 7.
10
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.度洛西汀与安慰剂治疗非重症慢性抑郁症的随机对照试验。
J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

引用本文的文献

1
Antidepressant Treatment Response Prediction With Early Assessment of Functional Near-Infrared Spectroscopy and Micro-RNA.通过功能近红外光谱和微小RNA的早期评估预测抗抑郁治疗反应
IEEE J Transl Eng Health Med. 2024 Nov 26;13:9-22. doi: 10.1109/JTEHM.2024.3506556. eCollection 2025.
2
Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.氯胺酮辅助心理治疗:文献的系统叙述性综述
J Pain Res. 2022 Jun 15;15:1691-1706. doi: 10.2147/JPR.S360733. eCollection 2022.
3
Dysthymic disorder: forlorn and overlooked?
恶劣心境障碍:被遗忘与忽视了吗?
Psychiatry (Edgmont). 2009 May;6(5):46-51.
4
Partial remission, residual symptoms, and relapse in depression.抑郁症的部分缓解、残留症状和复发
Dialogues Clin Neurosci. 2008;10(4):431-7. doi: 10.31887/DCNS.2008.10.4/espaykel.
5
New statistical proposals to evaluate the benefit/risk ratio of long-term treatment of depression: application to a one-year double-blind study comparing medifoxamine with fluoxetine.新的统计建议评估抑郁症长期治疗的获益/风险比:一项为期一年的双盲研究比较美法辛与氟西汀的应用。
Clin Drug Investig. 1998;15(4):285-95. doi: 10.2165/00044011-199815040-00004.
6
Chronic depression: a case series of 203 outpatients treated at a private practice.慢性抑郁症:203例在私人诊所接受治疗的门诊患者病例系列
J Psychiatry Neurosci. 1998 Jan;23(1):51-5.
7
Improving the treatment of depression in primary care: problems and prospects.改善基层医疗中抑郁症的治疗:问题与前景。
Br J Gen Pract. 1997 Sep;47(422):587-90.